Clinical Trial

Can Vitamin D Reduce the Burden of COVID-19?

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare the risks of COVID-19 in individuals from the Chicagoland area and other communities in the United States randomized to low (400 IU/day) versus moderate (4,000 IU/day) dose vitamin D.
Trial Details
NCT Number NCT07128069
Lead Sponsor University of Chicago
Collaborators: Cures Within Reach
Conditions COVID-19
Enrollment 2,093 participants
Start Date 2020-12-28
Primary Completion 2025-02-15 (estimated)
Study Completion 2025-12-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-07